HIV/Hepatitis External Quality Assessment

The RIQAS HIV/Hepatitis EQA programme is designed to monitor the performance of tests used to detect HIV/Hepatitis virus antibodies. All samples are conveniently supplied liquid ready-to-use and are suitable for qualitative methods of analysis.

  • Liquid ready-to-use
  • 100% human plasma
  • Quarterly reporting (5 samples per quarterly distribution)
  • Submit results and view reports online via RIQAS.Net
  • Suitable for both quantitative and qualitative methods of analysis

Not accredited to ISO/IEC 17043

Cat NoKit SizeFrequencyCycle StartParameters 
RQ91511.8ml
(samples shipped 4 times per year)
Quarterly reporting
(1 x 12 month cycle)
June10

[ddownload class="button tiny secondary" id="4294" text="Enrolment Document"]

[ddownload class="button tiny secondary" id="4295" text="Method Questionnaire"]

[ddownload class="button tiny secondary" id="2976" text="Instrument & Reagent Codes"]


Parameters

  • Anti-HIV-1
  • Anti-HCV
  • Anti-HTLV-II
  • HBsAg
  • Anti-HIV-2
  • Anti-HBc
  • Anti-HTLV-1&2 (combined)
  • Anti-HIV-1&2 (combined)
  • Anti-HTLV-I
  • Anti-CMV
Clinical Laboratory Survey